关注
Laurens A. van Kleef
Laurens A. van Kleef
MD PhD, Erasmus MC university Medical Center,
在 erasmusmc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1822022
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
LA van Kleef, HSJ Choi, WP Brouwer, BE Hansen, K Patel, RA de Man, ...
Jhep Reports 3 (5), 100350, 2021
822021
Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: focusing on the non‐overlap groups
I Ayada, LA van Kleef, LJM Alferink, P Li, RJ de Knegt, Q Pan
Liver International 42 (2), 277-287, 2022
762022
Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study
LA van Kleef, I Ayada, LJM Alferink, Q Pan, RJ de Knegt
Hepatology 75 (2), 419-429, 2022
762022
A global research priority agenda to advance public health responses to fatty liver disease
JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ...
Journal of hepatology 79 (3), 618-634, 2023
482023
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
M Serra-Burriel, A Juanola, F Serra-Burriel, M Thiele, I Graupera, E Pose, ...
The Lancet 402 (10406), 988-996, 2023
432023
Liver stiffness not fatty liver disease is associated with atrial fibrillation: the Rotterdam study
LA van Kleef, Z Lu, MA Ikram, NMS de Groot, M Kavousi, RJ de Knegt
Journal of Hepatology 77 (4), 931-938, 2022
382022
Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
LA van Kleef, RJ de Knegt, WP Brouwer
Hepatology 77 (3), 942-948, 2023
332023
Association of nonalcoholic fatty liver disease and fibrosis with incident dementia and cognition: the Rotterdam study
T Xiao, LA van Kleef, MK Ikram, RJ de Knegt, MA Ikram
Neurology 99 (6), e565-e573, 2022
302022
Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study
I Ayada, LA van Kleef, H Zhang, K Liu, P Li, YJ Abozaid, M Lavrijsen, ...
EBioMedicine 87, 2023
252023
Objectively measured physical activity is inversely associated with nonalcoholic fatty liver disease: the Rotterdam study
LA Van Kleef, A Hofman, T Voortman, RJ De Knegt
Official journal of the American College of Gastroenterology| ACG 117 (2 …, 2022
252022
Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
LA van Kleef, MJ Sonneveld, M Kavousi, MA Ikram, RA de Man, ...
Hepatology 77 (2), 585-593, 2023
172023
Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease–implications for the clinical utility of the EASL NIT guideline
LA van Kleef, MJ Sonneveld, RA de Man, RJ de Knegt
Journal of Hepatology 76 (1), 245-246, 2022
162022
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, N Fabrellas, ...
BMC public health 22 (1), 1385, 2022
152022
Plasma proteomic signature of fatty liver disease: The Rotterdam Study
YJ Abozaid, I Ayada, LA van Kleef, CL Vallerga, Q Pan, WP Brouwer, ...
Hepatology 78 (1), 284-294, 2023
112023
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population
LA van Kleef, RJ de Knegt, I Ayada, Q Pan, WP Brouwer
Hepatology Communications 7 (4), e0075, 2023
92023
The transition from NAFLD to MAFLD: One size still does not fit all—Time for a tailored approach?
LA van Kleef, RJ de Knegt
Hepatology 76 (5), 1243-1245, 2022
92022
Association between the presence of metabolic comorbidities and liver-related events in patients with chronic hepatitis B
LA Patmore, WK Katwaroe, D van der Spek, HSJ Choi, K Patel, ...
Clinical Gastroenterology and Hepatology 21 (12), 3089-3096. e1, 2023
72023
The new international nomenclature for steatotic liver disease: One step forward towards enhanced awareness for healthier life
KJ van Erpecum, LA van Kleef, U Beuers, RJ de Knegt
European Journal of Internal Medicine 117, 1-2, 2023
62023
Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study
LA van Kleef, MJ Sonneveld, F Zhu, MA Ikram, M Kavousi, RJ de Knegt
Liver International 43 (5), 1000-1007, 2023
62023
系统目前无法执行此操作,请稍后再试。
文章 1–20